CTNM Contineum Therapeutics, Inc. - Common stock
NASDAQ · Pharmaceuticals · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Jul 30, 2026
$13,12
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$8,60mínimo 52 semanas
$17,79máximo 52 semanas
P/E
-5.3
BPA
$-2.17
Ingresos
$0
tus insignias
Rango 52S
$9–$18
Calificación del Analista
STRONG BUY
Precio Objetivo
$22
P/E
-5.3
ROE
-27.7%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
CTNM Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$13.12
P/E
-5.3
BPA
$-2.17
Ingresos
$0
ROE
-27.7%
Rango 52S
$9–$18
CTNM Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02023-12-31 → 2024-12-31
BPA$-2.172023-12-31 → 2025-12-31
Flujo de caja libre$-56M2024-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | CTNM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -5.3 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | CTNM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -24.5% | · | -23.5% | En línea | |
| ROE | -27.7% | · | 18.3% | Débil | |
| ROIC | -26.1% | · | -26.1% | En línea |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | CTNM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 37.2 | · | 6.2 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 27.0 | · | 2.9 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | CTNM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-2.4%
Próximo informe
Oct 28, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 18, 2026 | $-0.40 | $-0.46 | 13.2% |
| 31 de marzo de 2026 | May 14, 2026 | $-0.39 | $-0.54 | 28.1% |
| 31 de diciembre de 2025 | $-0.49 | $-0.41 | -18.4% | |
| 30 de septiembre de 2025 | $-0.45 | $-0.49 | 8.8% | |
| 30 de junio de 2025 | $-0.62 | $-0.45 | -38.1% | |
| 31 de marzo de 2025 | $-0.62 | $-0.58 | -7.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | · | $0 | $50M | |
| R&D Expense | $52M | $38M | $28M | |
| SG&A Expense | $17M | $12M | $6M | |
| Operating Expenses | $68M | $51M | $34M | |
| Operating Income | $-68M | $-51M | $16M | |
| Interest Income | $8M | $9M | $5M | |
| Other Non-op | $-165.0K | $-163.0K | $-177.0K | |
| Pretax Income | $-60M | $-42M | $23M | |
| Income Tax | $0 | $0 | $450.0K | |
| Net Income | $-60M | $-42M | $23M | |
| EPS (Basic) | $-2.17 | $-2.18 | $1.36 | |
| EPS (Diluted) | $-2.17 | $-2.18 | $0.08 | |
| Shares (Basic) | 27,700,855 | 19,352,859 | 2,308,972 | |
| Shares (Diluted) | 27,700,855 | 19,352,859 | 3,395,514 | |
| EBITDA | $-68M | $-51M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $76M | $22M | $16M | |
| Short-term Investments | $187M | $183M | $110M | |
| Prepaid Expense | $5M | $2M | $3M | |
| Current Assets | $268M | $206M | $128M | |
| PP&E (Net) | $830.0K | $989.0K | $678.0K | |
| PP&E (Gross) | $3M | $3M | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | |
| Other Non-current Assets | $256.0K | $3.0K | $1M | |
| Total Assets | $277M | $213M | $130M | |
| Accounts Payable | $1M | $2M | $635.0K | |
| Accrued Liabilities | $6M | $7M | $4M | |
| Current Liabilities | $10M | $10M | $5M | |
| Capital Leases | $6M | $5M | $108.0K | |
| Other Non-current Liabilities | · | $0 | $110.0K | |
| Total Liabilities | $16M | $15M | $6M | |
| Common Stock | · | · | $2.0K | |
| Paid-in Capital | $438M | $315M | $7M | |
| Retained Earnings | $-177M | $-117M | $-75M | |
| AOCI | $260.0K | $71.0K | $108.0K | |
| Stockholders' Equity | $261M | $198M | $-68M | |
| Liabilities + Equity | $277M | $213M | $130M | |
| Shares Outstanding | · | · | 2,349,554 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $323.0K | $258.0K | $195.0K | |
| Stock-based Comp | $10M | $7M | $2M | |
| Other Non-cash | $-6M | $2M | · | |
| Operating Cash Flow | $-55M | $-33M | $19M | |
| CapEx | $231.0K | $514.0K | $414.0K | |
| Investing Cash Flow | $-4M | $-70M | $-66M | |
| Net Debt Issued | · | $0 | · | |
| Stock Issued | · | $108M | $0 | |
| Net Stock Activity | · | $108M | · | |
| Financing Cash Flow | $113M | $109M | $56M | |
| Net Change in Cash | $54M | $6M | $10M | |
| Taxes Paid | $1.0K | $1.0K | $450.0K | |
| Free Cash Flow | $-56M | $-33M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -24.5% | -24.6% | · | |
| ROE | -27.7% | -20.7% | · | |
| ROIC | -26.1% | -25.7% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 27.5 | 20.7 | · | |
| Quick Ratio | 27.0 | 20.5 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue / Share | · | $0.00 | · | |
| Cash Flow / Share | $-2.00 | $-1.70 | · | |
| EPS (TTM) | $-2.17 | $-2.18 | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | · | $0 | · | |
| Net Income TTM | $-60M | $-42M | · | |
| P/E | -5.3 | -6.7 | · | |
| Earnings Yield | -19.0% | -14.9% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $0 | $50M | |
| R&D Expense | $13M | $12M | $13M | $11M | $14M | $14M | $13M | $10M | $8M | $8M | $8M | $6M | $9M | |
| SG&A Expense | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $17M | $17M | $17M | $15M | $18M | $18M | $17M | $13M | $11M | $10M | $10M | $8M | $11M | |
| Operating Income | $-17M | $-17M | $-17M | $-15M | $-18M | $-18M | $-17M | $-13M | $-11M | $-10M | $-10M | $-8M | $39M | |
| Interest Income | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $679.0K | |
| Other Non-op | $-68.0K | $-57.0K | $-51.0K | $183.0K | $-167.0K | $-130.0K | $-46.0K | $-34.0K | $-77.0K | $-6.0K | $-47.0K | $-36.0K | $-76.0K | |
| Pretax Income | · | · | · | · | · | · | $-15M | $-10M | $-9M | $-8M | $-8M | $-6M | $42M | |
| Income Tax | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-161.0K | $-118.0K | $729.0K | |
| Net Income | $-15M | $-14M | $-15M | $-13M | $-16M | $-16M | $-15M | $-10M | $-9M | $-8M | $-8M | $-6M | $42M | |
| EPS (Basic) | $-0.40 | $-0.39 | $-0.48 | $-0.45 | $-0.62 | $-0.62 | $2.16 | $-0.40 | $-0.39 | $-3.55 | $3.61 | $-2.69 | $2.56 | |
| EPS (Diluted) | $-0.40 | $-0.39 | · | · | $-0.62 | $-0.62 | $-0.57 | $-0.40 | $-0.39 | · | $-0.35 | $-2.69 | $0.84 | |
| Shares (Basic) | 37,467,840 | 37,339,026 | · | 28,115,548 | 25,895,996 | 25,868,935 | · | 25,730,014 | 23,355,588 | 2,369,067 | · | 2,324,588 | 2,291,866 | |
| Shares (Diluted) | 37,467,840 | 37,339,026 | · | · | 25,895,996 | 25,868,935 | · | 25,730,014 | 23,355,588 | 2,369,067 | · | 2,324,588 | 3,511,757 | |
| EBITDA | $-17M | $-17M | · | $-15M | $-18M | $-18M | · | $-13M | $-11M | $-10M | · | · | · |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $20M | $76M | $43M | $21M | $22M | $22M | $41M | $77M | $16M | $16M | · | · | |
| Short-term Investments | $222M | $226M | $187M | $140M | $155M | $168M | $183M | $173M | $141M | $102M | $110M | · | · | |
| Prepaid Expense | $6M | $7M | $5M | $3M | $1M | $1M | $2M | $1M | $2M | $2M | $3M | · | · | |
| Current Assets | $243M | $253M | $268M | $185M | $177M | $192M | $206M | $215M | $220M | $120M | $128M | · | · | |
| PP&E (Net) | $929.0K | $1M | $830.0K | $880.0K | $856.0K | $891.0K | $989.0K | $888.0K | $801.0K | $756.0K | $678.0K | · | · | |
| PP&E (Gross) | · | · | $3M | · | · | · | $3M | · | · | · | $2M | · | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $1M | · | · | |
| Other Non-current Assets | $364.0K | $312.0K | $256.0K | $266.0K | $186.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3M | $1M | · | · | |
| Total Assets | $250M | $261M | $277M | $191M | $183M | $198M | $213M | $216M | $221M | $124M | $130M | · | · | |
| Accounts Payable | $505.0K | $1M | $1M | $786.0K | $2M | $4M | $2M | $1M | $734.0K | $570.0K | $635.0K | · | · | |
| Accrued Liabilities | $4M | $3M | $6M | $4M | $4M | $4M | $7M | $4M | $3M | $5M | $4M | · | · | |
| Current Liabilities | $7M | $7M | $10M | $6M | $7M | $9M | $10M | $6M | $4M | $6M | $5M | · | · | |
| Capital Leases | $4M | $5M | $6M | $4M | $4M | $5M | $5M | $0 | $113.0K | $111.0K | $108.0K | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $228.0K | $110.0K | · | · | |
| Total Liabilities | $11M | $11M | $16M | $10M | $11M | $13M | $15M | $6M | $4M | $7M | $6M | · | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | $2.0K | · | · | · | |
| Paid-in Capital | $447M | $442M | $438M | $342M | $321M | $318M | $315M | $312M | $310M | $8M | $7M | · | · | |
| Retained Earnings | $-207M | $-192M | $-177M | $-162M | $-149M | $-133M | $-117M | $-103M | $-93M | $-84M | $-75M | · | · | |
| AOCI | $-573.0K | $-253.0K | $260.0K | $265.0K | $147.0K | $170.0K | $71.0K | $561.0K | $-127.0K | $-58.0K | $108.0K | · | · | |
| Stockholders' Equity | $240M | $250M | $261M | $180M | $171M | $185M | $198M | $210M | $218M | $-76M | $-68M | · | · | |
| Liabilities + Equity | $250M | $261M | $277M | $191M | $183M | $198M | $213M | $216M | $221M | $124M | $130M | · | · | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | 2,384,426 | · | · | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $134.0K | $83.0K | $85.0K | $81.0K | $79.0K | $78.0K | $75.0K | $62.0K | $60.0K | $61.0K | $37.0K | $43.0K | $42.0K | |
| Stock-based Comp | $4M | $4M | $2M | $3M | $2M | $3M | $2M | $2M | $1M | $768.0K | $759.0K | $477.0K | $489.0K | |
| Other Non-cash | · | $-6M | · | · | · | $-1M | · | · | · | $-387.0K | · | · | · | |
| Operating Cash Flow | $-12M | $-16M | $-13M | $-12M | $-16M | $-14M | $-10M | $-6M | $-8M | $-8M | $-11M | $-5M | $41M | |
| CapEx | $6.0K | $312.0K | $42.0K | $98.0K | $44.0K | $47.0K | $166.0K | $82.0K | $119.0K | $147.0K | $309.0K | $22.0K | $31.0K | |
| Investing Cash Flow | $5M | $-39M | $-47M | $15M | $14M | $15M | $-9M | $-30M | $-39M | $9M | $9M | $-39M | $-44M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | |
| Financing Cash Flow | $1M | $129.0K | $93M | $19M | $91.0K | $24.0K | $642.0K | $13.0K | $108M | $-18.0K | $-321.0K | $10M | $47M | |
| Net Change in Cash | $-5M | $-55M | $33M | $22M | $-2M | $527.0K | $-19M | $-36M | $61M | $738.0K | $-2M | $-35M | $43M | |
| Free Cash Flow | · | $-17M | · | · | · | $-14M | · | · | · | $-8M | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -7.0% | -6.3% | · | -6.3% | -7.9% | -9.9% | · | -9.5% | -8.1% | -13.6% | · | · | · | |
| ROE | -7.4% | -6.7% | · | -6.6% | -8.2% | -29.3% | · | -9.8% | -8.3% | 22.3% | · | · | · | |
| ROIC | · | · | · | · | · | · | · | -6.2% | -5.0% | 13.1% | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 37.2 | 38.0 | · | 29.1 | 24.5 | 21.5 | · | 37.1 | 58.9 | 19.2 | · | · | · | |
| Quick Ratio | 36.2 | 37.0 | · | 28.7 | 24.3 | 21.3 | · | 36.8 | 58.5 | 18.9 | · | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | $-31.72 | · | · | · | |
| Revenue / Share | · | · | · | · | · | · | · | $0.00 | $0.00 | · | · | · | · | |
| Cash Flow / Share | · | $-0.44 | · | · | · | · | · | · | · | $-3.37 | · | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | $6.82 | · | · | · | |
| EPS (TTM) | · | · | · | $-2.21 | $-2.21 | $-1.98 | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-58M | $-58M | · | $-59M | $-57M | $-50M | · | $-35M | $-31M | $19M | · | · | · | |
| P/E | · | · | · | -5.3 | -1.8 | -3.5 | · | · | · | · | · | · | · | |
| Earnings Yield | · | · | · | -18.8% | -55.7% | -28.4% | · | · | · | · | · | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Ingresos | · | $0 | $50M |
| Beneficio neto | $-60M | $-42M | $23M |
| EPS Diluido | $-2.17 | $-2.18 | $0.08 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Ratio corriente | 27.5 | 20.7 | · |
| Ratio Rápido | 27.0 | 20.5 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Flujo de caja libre | $-56M | $-33M | · |
Propietarios institucionales (13F) 107 declarantes · $505.6M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
107
Valor en tenencia
$505.6M
Nuevas posiciones
28
Posiciones cerradas
15
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 28 (+5 vs trimestre anterior) | 15 (+4 vs trimestre anterior) | 33 (+3 vs trimestre anterior) | 19 (-1 vs trimestre anterior) | -2.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $46 569 464 | 2 841 334 | 9,21% | Acciones |
| JANUS HENDERSON GROUP PLC | $35 593 891 | 2 734 836 | 7,04% | Acciones |
| BlackRock, Inc. | $33 834 614 | 2 064 345 | 6,69% | Acciones |
| JOHNSON & JOHNSON | $32 438 645 | 1 979 173 | 6,42% | Acciones |
| FRANKLIN RESOURCES INC | $30 144 931 | 1 839 227 | 5,96% | Acciones |
| Balyasny Asset Management L.P. | $24 958 577 | 1 522 793 | 4,94% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $21 657 025 | 1 321 356 | 4,28% | Acciones |
| PERCEPTIVE ADVISORS LLC | $20 579 153 | 1 255 592 | 4,07% | Acciones |
| FMR LLC | $17 047 731 | 1 040 130 | 3,37% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $15 270 711 | 931 709 | 3,02% | Acciones |
| GREAT POINT PARTNERS LLC | $15 103 074 | 921 481 | 2,99% | Acciones |
| VANGUARD GROUP INC | $14 525 907 | 1 270 858 | 2,87% | Acciones |
| Longaeva Partners L.P. | $13 321 087 | 812 757 | 2,63% | Acciones |
| Ikarian Capital, LLC | $13 241 056 | 807 874 | 2,62% | Acciones |
| SECTORAL ASSET MANAGEMENT INC | $11 925 151 | 727 587 | 2,36% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $11 364 044 | 693 188 | 2,25% | Acciones |
| HHLR ADVISORS, LTD. | $10 970 433 | 669 337 | 2,17% | Acciones |
| RED TREE MANAGEMENT, LLC | $10 459 410 | 638 158 | 2,07% | Acciones |
| Versant Venture Management, LLC | $8 893 673 | 542 628 | 1,76% | Acciones |
| GOLDMAN SACHS GROUP INC | $8 150 009 | 497 255 | 1,61% | Acciones |
| Boxer Capital Management, LLC | $8 096 660 | 494 000 | 1,60% | Acciones |
| STATE STREET CORP | $6 980 534 | 425 902 | 1,38% | Acciones |
| CITADEL ADVISORS LLC | $6 496 242 | 396 354 | 1,28% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $5 375 920 | 328 000 | 1,06% | Acciones |
| SILVERARC CAPITAL MANAGEMENT, LLC | $4 853 653 | 296 135 | 0,96% | Acciones |
| ADAR1 Capital Management, LLC | $4 572 171 | 278 961 | 0,90% | Acciones |
| NORTHERN TRUST CORP | $4 553 208 | 277 804 | 0,90% | Acciones |
| Squadron Capital Management LLC | $4 261 400 | 260 000 | 0,84% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $3 643 972 | 222 329 | 0,72% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3 508 804 | 214 082 | 0,69% | Acciones |
| Ishara Investments LP | $3 359 950 | 205 000 | 0,66% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $3 007 155 | 183 475 | 0,59% | Acciones |
| Qube Research & Technologies Ltd | $2 989 749 | 182 413 | 0,59% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 955 150 | 180 302 | 0,58% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $2 925 440 | 178 673 | 0,58% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 905 636 | 177 281 | 0,57% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $2 471 563 | 150 797 | 0,49% | Acciones |
| Casdin Capital, LLC | $2 431 178 | 148 333 | 0,48% | Acciones |
| Eversept Partners, LP | $2 425 999 | 148 017 | 0,48% | Acciones |
| UBS Group AG | $2 141 223 | 130 642 | 0,42% | Acciones |
| DIADEMA PARTNERS LP | $1 962 424 | 119 733 | 0,39% | Acciones |
| MARSHALL WACE, LLP | $1 934 971 | 118 058 | 0,38% | Acciones |
| Trexquant Investment LP | $1 450 171 | 88 479 | 0,29% | Acciones |
| Verdad Advisers, LP | $1 327 819 | 81 014 | 0,26% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $1 293 499 | 78 920 | 0,26% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 238 412 | 75 559 | 0,24% | Acciones |
| Schonfeld Strategic Advisors LLC | $1 138 137 | 69 441 | 0,23% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 103 047 | 67 300 | 0,22% | Acciones |
| Bank of New York Mellon Corp | $1 075 249 | 65 604 | 0,21% | Acciones |
| ACUTA CAPITAL PARTNERS, LLC | $1 034 127 | 63 095 | 0,20% | Acciones |
Informantes de la empresa 13 insiders · 6 directivos · 8 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Carmine N. Stengone | CEO and President | 8 de septiembre de 2026 M | 17 217 | 0 | 7 | $-401 417 |
| Peter T Slover | Chief Financial Officer | 30 de enero de 2026 A | · | 0 | 0 | $0 |
| Daniel S. Lorrain | Chief Scientific Officer | 9 de julio de 2026 M | 135 202 | 0 | 19 | $-1 134 493 |
| Tim Watkins | CMO & Head of Development | 30 de junio de 2026 M | 8 961 | 0 | 5 | $-322 526 |
| John Stephen Healy | General Counsel and Corp Sec | 30 de enero de 2026 A | · | 0 | 0 | $0 |
| Stephen L. Huhn | CMO & Sr VP, Clinical Dev. | 31 de enero de 2025 A | 12 800 | 0 | 0 | $0 |
| Gines Diego Miralles | Consejero | 26 de junio de 2026 A | · | 0 | 0 | $0 |
| Todd R. Brady | Consejero | 26 de junio de 2026 A | · | 0 | 0 | $0 |
| Evert B. Schimmelpennink | Consejero | 26 de junio de 2026 A | · | 0 | 0 | $0 |
| Lori Lyons-Williams | Consejero | 26 de junio de 2026 A | · | 0 | 0 | $0 |
| Olivia C Ware | Consejero | 26 de junio de 2026 A | · | 0 | 0 | $0 |
| Sarah Boyce | Consejero | 26 de junio de 2026 A | · | 0 | 0 | $0 |
| Troy A. Ignelzi | Consejero | 26 de junio de 2026 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 17 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,09% | 90 712 SH | 11 de septiembre de 2026 | Diario |
| IBB · iShares Trust | 0,03% | 224 957 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 23 368 SH | 19 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 2 344 SH | 1 de octubre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 12 794 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 678 495 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 154 662 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,01% | 54 517 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 800 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 2 968 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 4 445 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 1 428 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1 762 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 308 647 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 982 259 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 272 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 253 552 SH | 11 de septiembre de 2026 | Diario |
CTNM Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$22.00
+67,7%
6 42,9%
Compra fuerte
6 42,9%
Compra
2 14,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
7 analistas · 2026-09-27Objetivo medio $22.14 +68,8%
← Por Debajo de Todos los Objetivos
Precio Actual $13.12
Mín$17.00
Media$22.14
Máx$28.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CTNM | · | -5.3 | · | · | -27.7% | · |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | · |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | · |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | · |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | · |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| AVIR | $279M | -1.8 | · | · | -49.5% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Jul 30, 2026